Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NXTC compared with LPCN: revenue, margins and what each company keeps, and the suppliers and customers both name
NXTC
NextCure, Inc.
Change
Mkt cap
Revenue
Revenue
LPCN
Lipocine Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NXTC
NextCure, Inc.
vs
LPCN
Lipocine Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
NXTC
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+4.47%
—
LPCN
2 of 4 reports
Report
implied
realized
× implied
Q3 FY26
—
▲
+6.25%
—
Q2 FY26
—
▲
+0.95%
—
= implied
NXTC realized, solid
LPCN realized, hatched
One scale, both sides: full bar = 7%
× = |realized| ÷ implied
Source: market data
NXTC
NextCure, Inc.
Change
5.10
▼
−0.39%
· post 5.10
Mkt cap
$24.4M
Revenue
—
Revenue
—
LPCN
Lipocine Inc.
Change
1.58
▲
+3.56%
· post 1.55
Closed
Nov 6 '26
Mkt cap
$17.4M
Revenue
$2M
Q3 FY26
Revenue
$2M
FY25
vs
Compare
Closed
Nov 6 '26
NXTC
NextCure, Inc.
vs
LPCN
Lipocine Inc.
5.10
▼
−0.39%
post 5.10
Price
1.58
▲
+3.56%
post 1.55
$24.4M
Mkt cap
$17.4M
—
Revenue
$2M
Q3 FY26
—
Revenue
$2M
FY25
Change
Change
NXTC
5.10
▼
−0.39%
vs
LPCN
1.58
▲
+3.56%
Closed
Nov 6 '26